Please login to the form below

Not currently logged in
Email:
Password:

ParagonRx appoints ex-FDA medical officer

Dr Stephen Sun joins consultancy as chief medical officer

Burlington, Massachusetts-based risk-benefit consultancy ParagonRx has appointed Dr Stephen Sun as its new chief medical officer.

Dr Sun was formerly a medical officer at US regulator the FDA and in his new role will provide regulatory and strategy advice on the optimal and safe use of new drugs and devices.

He began his pharmaceutical industry career at Organon, working in drug safety and medical knowledge management, before joining Alpharma as director of drug safety.

He was promoted to senior director of medical affairs and then after King Pharmaceuticals' acquisition of Alpharma, Dr Sun served as King's senior director of pharmacovigilance and risk management.

After gaining OTC experience at Reckitt-Benckiser, Dr Sun Sun joined the FDA as a medical officer, serving in the CDER Division of Risk Management and most recently in the Controlled Substances staff.

In his new role at ParagonRx, part of inVentiv Health, he will report directly to ParagonRx president Jeffrey Fetterman.

“The focus today is on enhanced pharmacovigilance, putting preventions in place before any regulatory body requires it,” Fetterman said. “Dr Sun's FDA experience will enrich the guidance we offer clients to assure that active risk management is at the core of developing all new products and services.”

21st August 2013

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....